PAPER Carlson C, Estergard W, Oh J, Suhy J, Jack CR, Siemers E, Barakos J
SEARCH RESULTS
330988 RESULTS
PAPER Mattsson N, Andreasson U, Persson S, Arai H, Batish SD, Bernardini S, Bocchio-Chiavetto L, Blankenstein MA, Carrillo MC, Chalbot S, Coart E, Chiasserini D, Cutler N, Dahlfors G, Duller S, Fagan AM, Forlenza O, Frisoni GB, Galasko D, Galimberti D, Hampel H, Handberg A, Heneka MT, Herskovits AZ, Herukka SK, Holtzman DM, Humpel C, Hyman BT, Iqbal K, Jucker M, Kaeser SA, Kaiser E, Kapaki E, Kidd D, Klivenyi P, Knudsen CS, Kummer MP, Lui J, Lladó A, Lewczuk P, Li QX, Martins R, Masters C, McAuliffe J, Mercken M, Moghekar A, Molinuevo JL, Montine TJ, Nowatzke W, O'Brien R, Otto M, Paraskevas GP, Parnetti L, Petersen RC, Prvulovic D, de Reus HP, Rissman RA, Scarpini E, Stefani A, Soininen H, Schröder J, Shaw LM, Skinningsrud A, Skrogstad B, Spreer A, Talib L, Teunissen C, Trojanowski JQ, Tumani H, Umek RM, Van Broeck B, Vanderstichele H, Vecsei L, Verbeek MM, Windisch M, Zhang J, Zetterberg H, Blennow K
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers.
Alzheimers Dement. 2011 Jul;7(4):386-395.e6. PubMed: 21784349PAPER Johnson SC, La Rue A, Hermann BP, Xu G, Koscik RL, Jonaitis EM, Bendlin BB, Hogan KJ, Roses AD, Saunders AM, Lutz MW, Asthana S, Green RC, Sager MA
The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ε3/ε3 genotype.
Alzheimers Dement. 2011 Jul;7(4):456-65. PubMed: 21784354PAPER Jack CR, Barkhof F, Bernstein MA, Cantillon M, Cole PE, Decarli C, Dubois B, Duchesne S, Fox NC, Frisoni GB, Hampel H, Hill DL, Johnson K, Mangin JF, Scheltens P, Schwarz AJ, Sperling R, Suhy J, Thompson PM, Weiner M, Foster NL
Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease.
Alzheimers Dement. 2011 Jul;7(4):474-485.e4. PubMed: 21784356PAPER Hornberger M, Geng J, Hodges JR
Convergent grey and white matter evidence of orbitofrontal cortex changes related to disinhibition in behavioural variant frontotemporal dementia.
Brain. 2011 Sep;134(Pt 9):2502-12. PubMed: 21785117PAPER Cornejo A, Jiménez JM, Caballero L, Melo F, Maccioni RB
Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer's disease.
J Alzheimers Dis. 2011 Jan 1;27(1):143-53. PubMed: 21785188PAPER David R, Friedman L, Mulin E, Noda A, Le Duff F, Kennedy Q, Garcia R, Robert PH, Yesavage JA, Zeitzer JM,
Lack of Association Between COMT Polymorphisms and Apathy in Alzheimer's Disease.
J Alzheimers Dis. 2011 Jan 1;27(1):155-61. PubMed: 21785189PAPER Facecchia K, Fochesato LA, Ray SD, Stohs SJ, Pandey S
Oxidative toxicity in neurodegenerative diseases: role of mitochondrial dysfunction and therapeutic strategies.
J Toxicol. 2011;2011:683728. PubMed: 21785590PAPER Atkins ER, Panegyres PK
The clinical utility of gene testing for Alzheimer's disease.
Neurol Int. 2011 Jun;3(1):e1. PubMed: 21785673PAPER Shibata N, Ohnuma T, Kuerban B, Komatsu M, Baba H, Arai H
Genetic Association between Akt1 Polymorphisms and Alzheimer's Disease in a Japanese Population.
Int J Alzheimers Dis. 2011;2011:762471. PubMed: 21785701PAPER Modarresi F, Faghihi MA, Patel NS, Sahagan BG, Wahlestedt C, Lopez-Toledano MA
Knockdown of BACE1-AS Nonprotein-Coding Transcript Modulates Beta-Amyloid-Related Hippocampal Neurogenesis.
Int J Alzheimers Dis. 2011;2011:929042. PubMed: 21785702PAPER Fortress AM, Buhusi M, Helke KL, Granholm AC
Cholinergic Degeneration and Alterations in the TrkA and p75NTR Balance as a Result of Pro-NGF Injection into Aged Rats.
J Aging Res. 2011;2011:460543. PubMed: 21785728PAPER Alexopoulos P, Sorg C, Förschler A, Grimmer T, Skokou M, Wohlschläger A, Perneczky R, Zimmer C, Kurz A, Preibisch C
Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer's disease measured by pulsed arterial spin labeling MRI.
Eur Arch Psychiatry Clin Neurosci. 2011 Jul 24; PubMed: 21786091PAPER Müller M, Cárdenas C, Mei L, Cheung KH, Foskett JK
Constitutive cAMP response element binding protein (CREB) activation by Alzheimer's disease presenilin-driven inositol trisphosphate receptor (InsP3R) Ca2+ signaling.
Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13293-8. PubMed: 21784978PAPER Chakroborty S, Stutzmann GE
Early calcium dysregulation in Alzheimer's disease: setting the stage for synaptic dysfunction.
Sci China Life Sci. 2011 Aug;54(8):752-62. PubMed: 21786198Current Filters
No filters selected